Blocking opiate signaling in this pathway could support current and future obesity treatments. Why do we crave sugary snacks on full stomach? To find out more about the brain's unique mechanism ...

Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has received a Distinguished ...

VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...

Blocking opiate signaling in this pathway could support current and future obesity treatments. READ ALSO: Ozempic can help curb alcohol cravings, new study shows Why do we crave sugary snacks on ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

In simple terms, the Institute explained that the same nerve cells that make us feel full also trigger our cravings for sweets afterward. In fact, they noted that even the "mere perception" of having ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that avoids the mind-altering, addictive qualities of the natural plant.

One pathway is conventionally regarded as being responsible for eliciting the primary physiological effects (the G-protein signalling pathway), and the other for switching that signal off (the ...

About Spine BioPharma Spine BioPharma is committed to developing non-opiate, non-surgical treatments ... and possesses suppressive and stimulatory signaling pathways. In many diseases, there ...

as a non-opioid treatment for moderate to severe acute pain in adults. Journavx's main ingredient works by targeting a pain-signaling pathway that involves sodium channels in the peripheral ...